Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI assessment of moderate versus deep neuromuscular blockade during laparoscopic donor nephrectomy
NL-OMON48996Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2019
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rocuronium, mivacurium and Sugammadex, sponsored by Radboud University Medical Center. Primary endpoint: Skin to sacral promontory distance. Started Jun 2019; status: active, not recruiting.
02
Drugs
rocuroniummivacuriumSugammadex
Beyond the preview
Go deeper on NL-OMON48996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48996.